December 14, 2009
Dilon Diagnostics Gamma-Guided Localization System Cleared by FDA 
December 2, 2009
First Lesion-localization System for Molecular Breast Imaging Proves to Be Highly Effective for Gamma-Guided Biopsy: Results Presented Today at RSNA
November 30, 2009
BSGI Makes Significant Impact on Detection of Breast Cancer in Patients with Negative Mammographic Findings (Bertrand)
November 30, 2009
Breast-Specific Gamma Imaging Proves Highly Sensitive for the Detection of Ductal Carcinoma In Situ (Brem)
November 30, 2009
Breast-Specific Gamma Imaging Identifies Occult Lesions Using Multi-Modality Imaging For Biopsy (Rapelyea)
November 30, 2009
Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer (Torrente)
November 19, 2009
Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI)
October 13, 2009
New Hope: Breast Cancer Detection Goes Beyond Mammography to See What Matters
October 11, 2009
Dilon Diagnostics Joins Forces With Philips for Women's Health Solutions
October 8, 2009
Breast Specific Gamma Imaging Proves Cost-Effective for Pre-Surgical Planning of Patients with Known Cancer Diagnosis
April 9, 2009
Further Testing with Breast-Specific Gamma Imaging (BSGI) Uncovers Additional Cancer in Breast Cancer Patients, Changes Surgical Management
April 9, 2009
Breast-Specific Gamma Imaging (BSGI) Study Receives Breast Journal Abstract Award
March 18, 2009
Breast-Specific Gamma Imaging (BSGI) Can Reduce the Number of Unnecessary Breast Biopsies When Compared to MRI
March 18, 2009
In Women Over the Age of 65, Breast-Specific Gamma Imaging (BSGI) Limits Biopsies, Costs for Diagnosing Breast Cancer
March 3, 2009
Breast-Specific Gamma Imaging (BSGI) Offers Greater Sensitivity Over Mammography, Ultrasound and MRI
February 27, 2009
Breast-Specific Gamma Imaging (BSGI) Uncovers Additional Cancer In Newly Diagnosed Breast Cancer Patients
February 10, 2009
Dilon Technologies Leads Molecular Breast Imaging Expansion
February 3, 2009
Dilon Technologies’ Slant15™ and LEHR Collimators Enhance Imaging Capabilities
